Literature DB >> 30215439

Organelle-specific analysis of labile Fe(ii) during ferroptosis by using a cocktail of various colour organelle-targeted fluorescent probes.

Tasuku Hirayama1, Ayaji Miki, Hideko Nagasawa.   

Abstract

Ferroptosis is an emerging type of cell death mode that is dependent on iron. Unfortunately, the detailed analysis of the function of organelle labile Fe(ii) in oxidative damage and lethality of the cells has not been demonstrated so far, mainly due to the lack of efficient methods to visualize labile Fe(ii) at the targeted organelles. We have recently reported a series of Fe(ii)-selective fluorescent probes, i.e., Ac-MtFluNox, Lyso-RhoNox, and ER-SiRhoNox, which can detect Fe(ii) specifically in the mitochondria, lysosomes, and endoplasmic reticulum (ER), respectively. These probes demonstrate similar reaction rates and off/on contrasts with various colours and intracellular distributions, enabling simultaneous multi-colour imaging that allows the monitoring of labile Fe(ii) levels at each targeted organelle. In this paper, by using a cocktail of these probes, we successfully visualised the aberrant elevation of labile Fe(ii) in the lysosomes and ER prior to HT1080 cell death induced by erastin, which is an inducer of ferroptosis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30215439     DOI: 10.1039/c8mt00212f

Source DB:  PubMed          Journal:  Metallomics        ISSN: 1756-5901            Impact factor:   4.526


  15 in total

1.  The synthesis and properties of mitochondrial targeted iron chelators.

Authors:  Agostino Cilibrizzi; Charareh Pourzand; Vincenzo Abbate; Olivier Reelfs; Laura Versari; Giuseppe Floresta; Robert Hider
Journal:  Biometals       Date:  2022-04-02       Impact factor: 2.949

Review 2.  Organelle-specific regulation of ferroptosis.

Authors:  Xin Chen; Rui Kang; Guido Kroemer; Daolin Tang
Journal:  Cell Death Differ       Date:  2021-08-31       Impact factor: 12.067

3.  The Detection of Divalent Iron and Reactive Oxygen Species During Ferroptosis with the Use of a Dual-Reaction Turn-On Fluorescent Probe.

Authors:  Yueqi Wang; Changjian Li; Jiaming Zhuo; Hui Hui; Bing Zhou; Jie Tian
Journal:  Mol Imaging Biol       Date:  2022-10-04       Impact factor: 3.484

Review 4.  The Organelle-Specific Regulations and Epigenetic Regulators in Ferroptosis.

Authors:  Yixuan Zhang; Mingrui Li; Yiming Guo; Shuang Liu; Yongguang Tao
Journal:  Front Pharmacol       Date:  2022-06-17       Impact factor: 5.988

5.  Heterogeneity of ferrous iron-containing endolysosomes and effects of endolysosome iron on endolysosome numbers, sizes, and localization patterns.

Authors:  Peter W Halcrow; Nirmal Kumar; Zahra Afghah; Jalyn P Fischer; Nabab Khan; Xuesong Chen; Olimpia Meucci; Jonathan D Geiger
Journal:  J Neurochem       Date:  2022-02-23       Impact factor: 5.546

6.  mTORC2 links growth factor signaling with epigenetic regulation of iron metabolism in glioblastoma.

Authors:  Kenta Masui; Mio Harachi; Shiro Ikegami; Huijun Yang; Hiromi Onizuka; William H Yong; Timothy F Cloughesy; Yoshihiro Muragaki; Takakazu Kawamata; Nobutaka Arai; Takashi Komori; Webster K Cavenee; Paul S Mischel; Noriyuki Shibata
Journal:  J Biol Chem       Date:  2019-11-11       Impact factor: 5.157

Review 7.  Emerging role of ferrous iron in bacterial growth and host-pathogen interaction: New tools for chemical (micro)biology and antibacterial therapy.

Authors:  Ryan L Gonciarz; Adam R Renslo
Journal:  Curr Opin Chem Biol       Date:  2021-03-11       Impact factor: 8.822

Review 8.  Ferrous Iron-Dependent Pharmacology.

Authors:  Ryan L Gonciarz; Eric A Collisson; Adam R Renslo
Journal:  Trends Pharmacol Sci       Date:  2020-11-28       Impact factor: 14.819

Review 9.  Ferroptosis in Liver Diseases: An Overview.

Authors:  Martina Maria Capelletti; Hana Manceau; Hervé Puy; Katell Peoc'h
Journal:  Int J Mol Sci       Date:  2020-07-11       Impact factor: 5.923

Review 10.  Epigenetic Regulation and Nonepigenetic Mechanisms of Ferroptosis Drive Emerging Nanotherapeutics in Tumor.

Authors:  Yue Cheng; Yao Xie; Yan Chen; Xiaojing Liu
Journal:  Oxid Med Cell Longev       Date:  2021-01-29       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.